Atlas Trials

Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel

Clinical trial NCT01539876 · WITHDRAWN

Trial details

NCT number
NCT01539876
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.